Cargando…
Allo-SCT for multiple myeloma: a review of outcomes at a single transplant center
Allogeneic stem cell transplant for multiple myeloma (MM) is one treatment associated with long-term disease-free survival. The high incidence of treatment-related mortality and relapses, however, are important reasons for controversy about the role of allografting in the management of MM. We review...
Autores principales: | Bensinger, W, Rotta, M, Storer, B, Chauncey, T, Holmberg, L, Becker, P, Sandmaier, B M, Storb, R, Maloney, D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3376198/ https://www.ncbi.nlm.nih.gov/pubmed/22327126 http://dx.doi.org/10.1038/bmt.2012.1 |
Ejemplares similares
-
Long-term follow up of tandem autologous-allogeneic hematopoietic cell transplantation for multiple myeloma
por: Maffini, Enrico, et al.
Publicado: (2019) -
Editorial: Strengths and Challenges of Allo-SCT in the Modern Era
por: Malagola, Michele, et al.
Publicado: (2022) -
Total body irradiation dose escalation decreases risk of progression and graft rejection after hematopoietic cell transplantation for myelodysplastic syndromes or myeloproliferative neoplasms
por: Monaco, Federico, et al.
Publicado: (2019) -
Outcomes of Allogeneic Stem Cell Transplant (allo-SCT) Recipients in the Era of Newer Antifungal Agents
por: Shah, Nishi, et al.
Publicado: (2014) -
What is known about palliative care in adult patients with allogeneic stem cell transplantation (allo-SCT)?
por: Simon, Steffen T., et al.
Publicado: (2021)